Stage-specific modulation of IFN-regulatory factor 4 function by Krüppel-type zinc finger proteins

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6104-6111

  Gupta, Sanjay ^a   Anthony, Alissa ^a   Pernis, Alessandra B ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 6; ZINC FINGER PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 0035873193     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6104     Document Type: Article

References (43)

1. Eisenbeis, C., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genet Dev. 9:1377.
2. Matsuyama, T., A. Grossman, H. Mittrucker, D. Siderovski, F. Kiefer, T. Kawakami, C. Richardson, T. Taniguchi, S. Yoshinaga, and T. Mak. 1995. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23:2127.
3. Yamagata, T., J. Nishida, T. Tanaka, R. Sakai, K. Mitani, T. Taniguchi, Y. Yazaki, and H. Hirai. 1996. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16:1283.
4. Gupta, S., M. Jiang, A. Anthony, and A. Pernis. 1999. Lineage-specific modulation of IL-4 signaling by inlerferon regulatory factor 4. J. Exp. Med. 190:1837.
5. Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, et al. 2000. Distinct types of diffuse large B-cell lymphorna identified by gene expression profiling. Nature 403:503.
6. Glynne, R., S. Akkaraju, J. I. Healy, J. Rayner, C. C. Goodnow, and D. H. Mack. 2000. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 403:672.
7. Mittrucker, H., T. Matsuyama, A. Grossman, T. Kundig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P. Ohashi, and T. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275:540.
8. Pongubala, J. M. R., S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Alchinsoti. 1992. PU.1 recruits a second nuclear factor to a site important for immunoglohulin κ 3′ enhancer activity. Mol. Cell. Biol. 12:368.
9. Himmelmann, A., A. Riva, G. L. Wilson, B. P. L. C. Thevenin, and J. H. Kehrl. 1997. PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. Blood 90:3984.
10. Bonnefoy, J.-Y., S. Lecoanet-Henchoz, J.-P. Aubry, J.-F. Gauchat, and P. Graber. 1995. CD23 and B-cell activation. Curr. Opin. Immunol. 7:355.
11. Conrad, D. 1990. FcεeRll/CD23: the low affinity receptor for IgE. Annu. Rev. Immunol. 8:623.
12. Richards, M., and D. Katz. 1991. Biology and chemistry of the low affinity IgE receptor (FcεRII/CD23). Crit. Rev. Immunol. 11:65.
13. Raulet, D., and W. Held. 1995. Natural killer receptors: the offs and ons of NK cell recognition. Cell 82:697.
14. Yokoyama, W. 1997. What goes up must come down: the emerging spectrum of inhibitory receptors. J. Exp. Med. 186:1803.
15. Kikutani, H., and T. Kishimoto. 1990. Molecular genetics and biology of two different species of FcεRII. Res. Immunol 141:249.
16. Vivier, E., and M. Daeron. 1997. Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 18:286.
17. Unkeless, J., and J. Jin. 1997. Inhibitory receptors, ITlM sequences and phosphatases. Curr. Opin. Immunol. 9:338.
18. Allman, D., A. Jain, A. Dent, R. Maile. T. Selvaggi, M. Kehry, and L. Staudt. 1996. BCL-6 expression during B-cell activation. Blood 87:5257.
19. Catoretti, G., C.-C. Chang, K. Cechova, J. Zhang, B. H. Ye, B. Falini, D. C. Louie, K. Offit, R. S. K. Chaganti, and R. Dalla-Favera. 1995. BCL-6 protein is expressed in germinal center B cells. Blood 1:45.
20. Catoretti, G., C. Chang, K. Cechova, J. Zhang, B. Ye, B. Falini, D. Louie. K. Offit, R. Chaganti, and R. Dalla-Favera. 1997. Down-regulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMPI) and its block in lymphoma carrying BCL-6 rearrangements. Blood 90(Suppl. l):175a.
21. Banchereau, J., and F. Rousset. 1992. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv. Immunol. 52:125.
22. Turner, C. A., D. Mack, and M. M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297.
23. Lin, Y., K. Wong, and K. Calame. 1997. Repression of c-myc transcription by Blimp1, an inducer of terminal B cell differentiation. Science 276:596.
24. Piskurich, J. F., K. Lin, Y. Lin, Y. Wang, J. P.-Y. Ting, and K. Calame. 2000. Blimp1/PRDI-BF1 mediates extinction of major histocompatibility class II transactivator (CIITA) expression in plasma cells. Nat. Immun. 1:526.
25. Keller, A. D., and T. Maniatis. 1991. Identification and characterization of a novel repressor of β-interferon gene expression. Genes Dev. 5:868.
26. Angelin-Duclos, C., G. Catoretti, K.-I. Lin, and K. Calame. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165:5462.
27. Chang, C., B. Ye, R. Chaganti, and R. Dalla-Favera. 1996. BCL-6. aPOZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA 93:6947.
28. Perkel, J. M., and M. L. Atchison. 1998. A two-step mechanism for recruitment of Pip by PU.1. J. Immunol. 160:241.
29. Kotanides, H., and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activalion of a DNA binding factor by IL-4. Science 262:1265.
30. Goldstein, M., J. Hoxie, D. Zembryki, D. Matthews, and A. I. Levinson. 1985. Phenotypic and functional analysis of B cell lines from patients with multiple myeloma. Blood 66:444
31. Tuscano, J. M., K. M. Druey, A. Riva, J. Pena, C. B. Thompson, and J. H. Kehrl. 1996. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 88:1359.
32. Harris, M. B., C.-C. Chang, M. T. Berton, N. N. Danial, J. Zhang, D. Kuehner, B. H. Ye, M. Kvatyuk, P. P. Pandolfi, O. Caloretti, et al. 1999. Transcriptional repression of Stato-dependent interleukin-4-induced genes by BCL-6: specific reguallion of Iε transcription and immunoglobulin E switching. Mol. Cell. Biol. 19:7264.
33. Ortiz, M. A., J. Light, R. A. Maki, and N. Assa-Munt. 1999. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions. Proc. Natl. Acad. Sci. USA 96:2740.
34. Dent, A. L., A. L. Shaffer, X. Yu, D. Allman, and L. M. Slaudt. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589.
35. Ye, B., F. Lista, F. L. Coco, D. Knowles, K. Offit, R. Chaganti, and R. Dalla-Favera. 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747.
36. Seyfert, V., D. Allman, Y. He, and L. Staudt. 1996. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 12:2331.
37. Liu, Y.-J. 1997. Tracing antigen-driven B cell development in humans. Chem. Immunol. 67:14.
38. Shaffer, A. L., X. Yu, Y. He, J. Boldrick, E. P. Chan, and L. M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation. and cell cycle control. Immunity 13:199.
39. Iida, S., P. Rao, M. Butler, P. Corradini, M. Boccadoro, B Klein, R. Chaganti, and R. Dalla-Favera. 1997. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17:226.
40. Baron, B. W., G. Nucifora, N. McCabe, R. Espinosa, M. M. L. Beau, and T. W. McKeithan. 199.3. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q.32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc. Natl. Acad Sci. USA 90:5262.
41. Kerckaert, J. P., C. Deweindt, H. Tilly, S. Quief, G. Lecocq, and C. Bastard. 1993. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat. Genet. 5:66.
42. Miki, T., N. Kawamata, S. Hirosawa, and N. Aoki. 1994. Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. Blood 83:26.
43. Mock, B. A., L. Liu, D. L. Paslier, and S. Huang. 1996. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRD1-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10. Genomics 37:24.